By Professor Monica M. Lahra

Book Chapters

George CRR; Jeffery HE; Lahra MM, 2022, 'Infection of mother and baby', in Keeling's Fetal and Neonatal Pathology, pp. 207 - 245, http://dx.doi.org/10.1007/978-3-030-84168-3_9

George CRR; Smith HV; Lahra MM, 2022, 'Neisseria meningitidis', in Molecular Typing in Bacterial Infections, Volume I: Second Edition, pp. 85 - 99, http://dx.doi.org/10.1007/978-3-030-74018-4_3

Goire N; Speers DJ; Lahra MM; Whiley DM, 2016, 'Neisseria gonorrhoeae: The Pathogen, Diagnosis, and Antimicrobial Resistance', in Singh SK (ed.), HUMAN EMERGING AND RE-EMERGING INFECTIONS: VIRAL AND PARASITIC INFECTIONS, VOL 1, JOHN WILEY & SONS INC, pp. 683 - 697, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000470861900038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

George CRR; Lahra MM; Jeffery HE, 2015, 'The impact of infection during pregnancy on the mother and baby', in Keeling's Fetal and Neonatal Pathology, pp. 219 - 256, http://dx.doi.org/10.1007/978-3-319-19207-9_9

Jeffery HE; Lahra MM, 2007, 'The Impact of Infection During Pregnancy on the Mother and Baby', in Fetal and Neonatal Pathology, Springer London, pp. 379 - 423, http://dx.doi.org/10.1007/978-1-84628-743-5_16

Journal articles

Lahra MM; Latham NH; Templeton DJ; Read P; Carmody C; Ryder N; Ellis SE; Madden EF; Parasuraman A; Wells J; Sheppeard V; Armstrong BH; Holland J; Pendle S; Sherry N; Leong L; Papanicolas L; Selvey CE; Van Hal SJ, 2024, 'Investigation and response to an outbreak of Neisseria meningitidis serogroup Y ST-1466 urogenital infections, Australia', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.20

Ouk V; Heng LS; Virak M; Deng S; Lahra MM; Frankson R; Kreisel K; McDonald R; Escher M; Unemo M; Wi T; Maatouk I; Mom PK; Fensham V; Kersh E; Cavailler P; Mundade Y; van Hal SJ; Kundu RL; Hogan TR; Whiley DM; Izumi K; Nishijima T, 2024, 'High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022-23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)', JAC-Antimicrobial Resistance, 6, http://dx.doi.org/10.1093/jacamr/dlae053

Lahra MM; Van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2023', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.13

Lahra MM; Van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2023', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.12

Lahra MM; Van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2023', Communicable diseases intelligence (2018), 48, http://dx.doi.org/10.33321/cdi.2024.48.14

Lahra MM; Hogan TR, 2023, 'Meningococcal Surveillance Australia - Reporting period 1 January to 31 March 2023', Communicable diseases intelligence (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.59

Van Hal SJ; Whiley DM; Le T; Ray S; Kundu RL; Kerr E; Lahra MM, 2023, 'Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype', Journal of Antimicrobial Chemotherapy, 78, pp. 2203 - 2208, http://dx.doi.org/10.1093/jac/dkad221

Ouk V; Pham CD; Wi T; van Hal SJ; Lahra MM, 2023, 'The Enhanced Gonococcal Surveillance Programme, Cambodia', The Lancet Infectious Diseases, 23, pp. e332 - e333, http://dx.doi.org/10.1016/S1473-3099(23)00479-6

Lahra MM; Van Hal S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme Annual Report, 2022', Communicable diseases intelligence (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.45

Lahra MM; George CR; Van Hal S; Hogan TR, 2023, 'Australian Meningococcal Surveillance Programme Annual Report, 2022', Communicable diseases intelligence (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.44

George CRR; Lahra MM; Nguyen T; Gatus B, 2023, 'Disc Test for Detecting Staphylococcus aureus Strains Producing Type A and Type C b-Lactamases', Microbiology Spectrum, 11, http://dx.doi.org/10.1128/spectrum.00220-23

Whiley DM; Tickner JA; Kundu RL; Hogan TR; van Hal SJ; Lahra MM, 2023, 'Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis', The Lancet Infectious Diseases, 23, pp. e268 - e269, http://dx.doi.org/10.1016/S1473-3099(23)00359-6

Bell SFE; Ware RS; Lewis DA; Lahra MM; Whiley DM, 2023, 'Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysis', The Lancet Microbe, 4, pp. e544 - e551, http://dx.doi.org/10.1016/S2666-5247(23)00071-X

Lahra MM; Hurley S; Ray S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2022.', Commun Dis Intell (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.28

Lahra MM; Hurley SM; Ray S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2022.', Commun Dis Intell (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.29

Lahra MM; Hurley SM; Van Hal S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme, 1 October to 31 December 2022.', Commun Dis Intell (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.30

Lahra MM; Hurley SM; Hogan TR, 2023, 'Meningococcal Surveillance Australia Reporting period 1 October to 31 December 2022.', Commun Dis Intell (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.23

Lahra MM; Ray S; Hogan TR, 2023, 'Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2022', Communicable diseases intelligence (2018), 47, http://dx.doi.org/10.33321/cdi.2023.47.4

O'Brien A; Hart J; Higgins A; Arthur I; Lee GH; Leung M; Kennedy K; Bradbury S; Foster S; Warren S; Korman TM; Abbott IJ; Heney C; Bletchley C; Warner M; Wells N; Wilson D; Varadhan H; Stevens R; Lahra M; Newton P; Maley M; van Hal S; Ingram PR, 2023, 'Nocardia species distribution and antimicrobial susceptibility within Australia', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.16234

Lahra MM; Ray S; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 April to 30 June 2022', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.81

Ayfan AKS; Macdonald J; Irwin AD; Zowawi HM; Forde BM; Paterson DL; Lahra MM; Whiley DM, 2022, 'Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility', Journal of Antimicrobial Chemotherapy, 77, pp. 2933 - 2936, http://dx.doi.org/10.1093/jac/dkac242

Tickner JA; Lahra MM; Whiley DM, 2022, 'The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae', The Lancet Infectious Diseases, 22, pp. 1271 - 1272, http://dx.doi.org/10.1016/S1473-3099(22)00520-5

Lahra MM; Hogan TR; Armstrong BH, 2022, 'Australian Gonococcal Surveillance Programme Annual Report, 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.52

Lahra MM; Ray S; Hogan TR, 2022, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2022', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.56

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Australian Gonococcal Surveillance Programme, 1 October to 31 December 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.43

Lahra MM; George CR; Hogan TR, 2022, 'Australian Meningococcal Surveillance Programme Annual Report, 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.46

Lahra MM; Ray S; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2022', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.36

George CR; Booy R; Nissen MD; Lahra MM, 2022, 'The decline of invasive meningococcal disease and influenza in the time of COVID-19: the silver linings of the pandemic playbook', Medical Journal of Australia, 216, pp. 504 - 507, http://dx.doi.org/10.5694/mja2.51463

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 October to 31 December 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.21

Hui BB; Padeniya TN; Rebuli N; Gray RT; Wood JG; Donovan B; Duan Q; Guy R; Hocking JS; Lahra MM; Lewis DA; Whiley DM; Regan DG; Seib KL, 2022, 'A Gonococcal Vaccine Has the Potential to Rapidly Reduce the Incidence of Neisseria gonorrhoeae Infection among Urban Men Who Have Sex with Men', Journal of Infectious Diseases, 225, pp. 983 - 993, http://dx.doi.org/10.1093/infdis/jiab581

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2021', Communicable diseases intelligence (2018), 46, http://dx.doi.org/10.33321/cdi.2022.46.1

Cabrera-Aguas M; Khoo P; George CRR; Lahra MM; Watson SL, 2022, 'Predisposing factors, microbiological features and outcomes of patients with clinical presumed concomitant microbial and herpes simplex keratitis', Eye (Basingstoke), 36, pp. 86 - 94, http://dx.doi.org/10.1038/s41433-021-01440-1

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2021', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.68

Lahra MM; Shoushtari M; Hogan T, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2021', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.63

Duan Q; Carmody C; Donovan B; Guy RJ; Hui BB; Kaldor JM; Lahra MM; Law MG; Lewis DA; Maley M; McGregor S; McNulty A; Selvey C; Templeton DJ; Whiley DM; Regan DG; Wood JG, 2021, 'Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia', PLoS Computational Biology, 17, pp. e1009385, http://dx.doi.org/10.1371/journal.pcbi.1009385

Unemo M; Lahra MM; Escher M; Eremin S; Cole MJ; Galarza P; Ndowa F; Martin I; Dillon JAR; Galas M; Ramon-Pardo P; Weinstock H; Wi T, 2021, 'WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study', The Lancet Microbe, 2, pp. e627 - e636, http://dx.doi.org/10.1016/S2666-5247(21)00171-3

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.58

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme 1 October to 31 December 2020', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.44

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2021', Communicable diseases intelligence (2018), 45

Lahra MM; George CRR; Shoushtari M; Hogan TR, 2021, 'Australian Meningococcal Surveillance Programme Annual Report, 2020', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.46

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Communicable Diseases Intelligence', COMMUNICABLE DISEASES INTELLIGENCE, 45, http://dx.doi.org/10.33321/cdi.2021.45.47

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2021', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.45

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2020', Communicable diseases intelligence (2018), 45, http://dx.doi.org/10.33321/cdi.2021.45.36

Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR, 2021, 'Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18', Journal of Antimicrobial Chemotherapy, 76, pp. 1815 - 1821, http://dx.doi.org/10.1093/jac/dkab099

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', COMMUNICABLE DISEASES INTELLIGENCE, 45, http://dx.doi.org/10.33321/cdi.2021.45.24

Back to profile page